Article (Scientific journals)
The lipid transfer protein STARD7 controls intestinal tumor development in a context-dependent manner.
Shostak, Kateryna; Chen, Yu; Maurizy, Chloé et al.
2026In EMBO Molecular Medicine
Peer Reviewed verified by ORBi
 

Files


Full Text
Published PDF STARD7 in intestinal cancers.pdf
Publisher postprint (10.35 MB) Creative Commons License - Attribution
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Inflammation-driven Intestinal Cancers; STARD7; Wnt-driven Tumor Initiation; mTORC1
Abstract :
[en] The role of phosphatidylcholine transporters such as Stard7 in intestinal cancer development is unknown. To explore this issue, we generated a mouse model lacking Stard7 in intestinal epithelial cells (IECs). Loss of Stard7 impaired mitochondrial Complex I activity, led to a severe metabolic and lipid reprogramming, enhanced mitochondrial ROS production and potentiated an mTORC1/ATF4 signature. As a result, levels of enzymes involved in serine biosynthesis were enhanced in Stard7-deficient IECs. We next assessed the consequences of Stard7 deficiency in both Wnt-dependent tumor initiation and in inflammation-driven tumor development. Strikingly, despite generating similar molecular signatures, Stard7 deficiency inhibited tumor development in Azoxymethane (AOM)/Dextran Sulfate Sodium (DSS)-treated mice but promoted Wnt-driven cancer initiation in the intestine. Apc+/Min mice lacking Stard7 in IECs developed more tumors in the distal colon as well as a specific microbiota signature. Collectively, our results suggest that the genetic status critically controls the effects of Stard7 deficiency on intestinal tumor development.
Disciplines :
Oncology
Author, co-author :
Shostak, Kateryna ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Chen, Yu ;  Université de Liège - ULiège > Département de pharmacie
Maurizy, Chloé  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Rademaker, Gilles  ;  Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Xu, Xinyi;  Laboratory of Cancer Biology, GIGA Cancer, University of Liege, Sart-Tilman, Liège, Belgium
Blomme, Arnaud  ;  Université de Liège - ULiège > Département de pharmacie
Close, Pierre  ;  Université de Liège - ULiège > Département de pharmacie ; WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WEL Research Institute, WELBIO Department, Wavre, Belgium
Renson, Olivier ;  GIGA Genomics Platform, University of Liege, Liege, Belgium
Van Hul, Matthias;  Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI) and Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium
Cani, Patrice D ;  WELBIO-Walloon Excellence in Life Sciences and Biotechnology, WEL Research Institute, WELBIO Department, Wavre, Belgium ; Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI) and Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium ; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom
Klein, Sebastian;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany ; Department of Hematology and Stem Cell Transplantation, University Duisburg-Essen, University Hospital Essen, Essen, Germany
Florin, Alexandra;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany
Büttner, Reinhard ;  Institute for Pathology-University Hospital of Cologne, Cologne, Germany
Cataldo, Didier  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et pathologiques
Delvenne, Philippe ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Nemazanyy, Ivan ;  Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS 3633, Paris, France
WATHIEU, Caroline  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Hego, Alexandre  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Ormenese, Sandra ;  Université de Liège - ULiège > GIGA > GIGA Platforms - Imaging & Flow cytometry
Peulen, Olivier  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Thiry, Marc  ;  Université de Liège - ULiège > Département des sciences de la vie > Service collectif des enseignements de biologie en bachelier
Krishnankutty, Roopesh ;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
Marques, Jair;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
von Kriegsheim, Alex;  Institute of Genetics and Cancer, Edinburgh Cancer Research, Edinburgh, Scotland
Chariot, Alain  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
More authors (15 more) Less
Language :
English
Title :
The lipid transfer protein STARD7 controls intestinal tumor development in a context-dependent manner.
Publication date :
30 March 2026
Journal title :
EMBO Molecular Medicine
ISSN :
1757-4676
eISSN :
1757-4684
Publisher :
Springer Science and Business Media LLC, Germany
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
WELBIO - Walloon Excellence in Life Sciences and Biotechnology
Belgian Foundation against Cancer
ULiège - University of Liège
EOS - The Excellence Of Science Program
F.R.S.-FNRS - Fonds de la Recherche Scientifique
UCL - Catholic University of Louvain
Available on ORBi :
since 03 May 2026

Statistics


Number of views
44 (2 by ULiège)
Number of downloads
38 (1 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi